Jaguar Health (JAGX) Revenue (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Revenue of $20.3 million for Q1 2026, up 815.63% year-over-year from $2.2 million in Q1 2025, and up 526.65% quarter-over-quarter from $3.2 million in Q4 2025.
Jaguar Health (JAGX) Revenue (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Revenue for 12 consecutive years, with $20.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 815.63% year-over-year to $20.3 million; the TTM figure through Mar 2026 stood at $29.6 million (up 155.96% YoY), while the FY2025 annual figure was $11.5 million, down 1.52% from the prior year.
- Revenue climbed to $20.3 million in Q1 2026 per JAGX's latest filing, from $3.2 million in the prior quarter.
- Across five years, Revenue topped out at $20.3 million in Q1 2026 and bottomed at $20000.0 in Q1 2022.
- Historically, Revenue has averaged $3.4 million across 5 years, with a median of $2.8 million in 2023.
- Annual changes were most pronounced in 2022 — Revenue tumbled 98.46% — and 2023, when it soared 7087.5%.
- Jaguar Health's Revenue stood at $32000.0 in 2022, then jumped by 7087.5% to $2.3 million in 2023, then surged by 52.57% to $3.5 million in 2024, then fell by 7.81% to $3.2 million in 2025, then jumped by 526.65% to $20.3 million in 2026.
- Business Quant data shows JAGX's Revenue at $20.3 million in Q1 2026, $3.2 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 20.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.27 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 2.81 Mn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 2.92 Mn |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 2.08 Mn |
| Sep 30, 2021 | 615,000.00 |
| Jun 30, 2021 | 379,000.00 |